GridAI Technologies Corp. (GRDX): debt financing — Entero Therapeutics enters up to $5M securities purchase agreement with initial $500k closing

GridAI Technologies Corp.

Initial closing of $500k non-interest bearing promissory note due one year and one day from issuance.
Warrants to purchase up to 1.52M shares at $2.50/share, exercisable after stockholder approval.
Company may hold subsequent closings for remaining $4.5M through Final Closing Date.
Proceeds for general corporate purposes, including working capital and potential acquisitions.
Note is not convertible; maturity may be extended in one-year increments.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

GridAI Technologies Corp. incurred debt of $500,000 with an investor at does not bear interest maturing one year and one day after its date of issuance.

Principal: $500,000
Counterparty: an investor
Rate: does not bear interest
Maturity: one year and one day after its date of issuance
Event: incurrence

Exact text from the filing

Initial Closing took place on October 17, 2025, pursuant to which the Company sold to the Investor: (i) a Note in the principal amount of $500,000

View on SEC.gov

88 debt financings filed in the last 30 days. Browse all debt financings →

GridAI Technologies Corp. filing history →

Source: SEC EDGAR

accession 0001104659-25-101519

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.